Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Otitis Media Bacterial Infections Bacterial Infections and Mycoses Ear Diseases Gram-Positive Bacterial Infections Infections OTITIS MEDIA WITH EFFUSION Otitis Otorhinolaryngologic Diseases Pneumococcal Infections Streptococcal Infections

Age range

6 month–24 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Auch, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Infants aged from 6 to 24 months
Presenting with AOM (ear infection)
Patients must not have received any antibiotic therapy within the past 7 days.

Other inclusion applies.

Exclusion criteria

Treatment and study plan

Prevenar

Drug

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)

Important dates

Study start: 2005
Primary completion: 2006
Study completion: 2006
First posted: Sep 19, 2005
Registry last updated: Jun 29, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed